Roche is integrating the new tool into its Navify digital platform, which offers a range of solutions to network laboratories and clinics.
Keystone-SDA
A new tool to evaluate kidney function developed by Swiss pharma firm Roche and which uses artificial intelligence has passed a regulatory test. The Chronic Kidney Disease algorithm panel has received the European CE marking of conformity, the Basel-based company announced on Monday.
+Get the most important news from Switzerland in your inbox
The new tool is designed to help assess the progression of kidney function loss. It can be used in patients diagnosed with chronic kidney disease and adults with diabetes or hypertension who are at high risk of reduced kidney function.
“Chronic kidney disease affects more than 700 million people worldwide and is widely recognised as a global health challenge,” Roche said in a statementExternal link. “With early diagnosis and appropriate treatment, it is possible to delay or prevent the decline in kidney function and reduce cardiovascular health risks, as well as related healthcare costs.”
More
More
How a clash with Roche exposed cracks in Swiss drug pricing system
The tool is already available in Europe and the United Kingdom, with the United States, Middle East and Asia to follow at a later date. Roche is integrating the new tool into its Navify digital platform, which offers a range of solutions to network laboratories and clinics, optimising their workflows.
Founded in 1896 in Basel by bank clerk Fritz Hoffmann-La Roche (1868-1929), the Roche Group was one of the first industrial manufacturers of medicines. Over the decades, several of its preparations have made medical history. Today, the company is active in numerous countries and has particularly significant market shares in the fields of cancer drugs and diagnostics. In 2024, the company posted revenues of CHF60.5 billion ($76 billion) and a net profit of CHF 9.2 billion.
Translated from Italian with DeepL/gw
We select the most relevant news for an international audience and use automatic translation tools to translate them into English. A journalist then reviews the translation for clarity and accuracy before publication.
Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team from news agencies such as Bloomberg or Keystone.
If you have any questions about how we work, write to us at english@swissinfo.ch.
